Reconstitution of the myxothiazol biosynthetic gene cluster by red/ET recombination and heterologous expression in Myxococcus xanthus

Applied and Environmental Microbiology

Volumn 72, Issue 12, 2006, Pages 7485-7494

  Perlova, Olena ^a   Fu, Jun ^b   Kuhlmann, Silvia ^a   Krug, Daniel ^a   Stewart, A Francis ^c   Zhang, Youming ^b   Müller, Rolf ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Gene Bridges GmbH   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; DRUG PRODUCTS; GENES; GENETIC ENGINEERING; METABOLITES;

AGROCHEMICAL ACTIVITIES; COSMID LIBRARY; GENE CLUSTERS; MYXOCOCCUS XANTHUS;

BIOSYNTHESIS;

AGRICULTURAL CHEMICAL; MYXOTHIAZOL;

CHROMOSOME; COLIFORM BACTERIUM; GENE EXPRESSION; RECOMBINATION; SECONDARY METABOLITE;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL METABOLISM; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; COSMID; DNA INTEGRATION; ESCHERICHIA COLI; GENE CLUSTER; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC RECOMBINATION; MYXOCOCCUS XANTHUS; NONHUMAN; STIGMATELLA AURANTIACA;

BACTERIAL PROTEINS; BIOTECHNOLOGY; CARDIOPULMONARY RESUSCITATION; CLONING, MOLECULAR; COSMIDS; ELECTROPORATION; ESCHERICHIA COLI; METHACRYLATES; MULTIGENE FAMILY; MYXOCOCCUS XANTHUS; RECOMBINATION, GENETIC; STIGMATELLA; THIAZOLES;

ESCHERICHIA COLI; MYXOCOCCALES; MYXOCOCCUS XANTHUS; STIGMATELLA AURANTIACA;

EID: 33845511743     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.01503-06     Document Type: Article

References (49)

1. Aldrich, C. C., B. J. Beck, R. A. Fecik, and D. H. Sherman. 2005. Biochemical investigations of pikromycin biosynthesis employing native penta- and hexaketide chain elongation intermediates. J. Am. Chem. Soc. 127:8441-8452.
2. Becker, W. F., G. von Jagow, T. Anke, and W. Steglich. 1981. Oudemansin, strobilurin A, strobilurin B and myxothiazol: new inhibitors of the bel segment of the respiratory chain with an E-beta-methoxyacrylate system as common structural element. FEBS Lett. 132:329-333.
3. Bode, H. B., and R. Müller. 2006. Analysis of myxobacterial secondary metabolism goes molecular. J. Ind. Microbiol. Biotechnol. 33:577-588.
4. Bode, H. B., and R. Müller. 2005. The impact of bacterial genomics on natural product research. Angew. Chem. Int. Ed. 44:6828-6846.
5. Bollag, D. M., P. A. McQueney, J. Zhu, O. Hensens, L. Koupal, J. Liesch, M. Goetz, E. Lazarides, and M. Woods. 1995. Epothilones, a new class of microtubule-stabilizing agents with Taxol-like mechanism of action. Cancer Res. 55:2325-2333.
6. Brady, S. F., C. J. Chao, J. Handelsman, and J. Clardy. 2001. Cloning and heterologous expression of a natural product biosynthetic gene cluster from eDNA. Org. Lett. 3:1981-1984.
7. Del Vecchio, F., H. Petkovic, S. G. Kendrew, L. Low, B. Wilkinson, R. Lill, J. Cortes, B. A. Rudd, J. Staunton, and P. F. Leadlay. 2003. Active-site residue, domain and module swaps in modular polyketide synthases. J. Ind. Microbiol. Biotechnol. 30:489-494.
8. Gaitatzis, N., A. Hans, R. Müller, and S. Beyer. 2001. The mtaA gene of the myxothiazol biosynthetic gene cluster from Stigmatella aurantiaca DW4/3-1 encodes a phosphopantetheinyl transferase that activates polyketide synthases and polypeptide synthetases. J. Biochem. 129:119-124.
9. Gerth, K., N. Bedorf, H. Irschik, G. Höfle, and H. Reichenbach. 1994. The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties. J. Antibiot. 47:23-31.
10. Gerth, K., H. Irschik, H. Reichenbach, and W. Trowitzsch. 1980. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties. J. Antibiot. 33:1474-1479.
11. Gerth, K., S. Pradella, O. Perlova, S. Beyer, and R. Müller. 2003. Myxobacteria: proficient producers of novel natural products with various biological activities-past and future biotechnological aspects with the focus on the genus Sorangium. J. Biotechnol. 106:233-253.
12. Gross, F., N. Luniak, O. Perlova, N. Gaitatzis, H. Jenke-Kodama, K. Gerth, D. Gottschalk, E. Dittmann, and R. Müller. 2006. Bacterial type III polyketide synthases: phylogenetic analysis and potential for the production of novel secondary metabolites by heterologous expression in pseudomonads. Arch. Microbiol. 185:28-38.
13. Gross, F., M. W. Ring, O. Perlova, J. Fu, S. Schneider, K. Gerth, S. Kuhlmann, F. Stewart, Y. Zhang, and R. Müller. Red/ET-subcloning and heterologous expression of methylmalonyl-CoA biosynthesis genes of Sorangium cellulosum So ce56 in Pseudomonas putida KT2440. Chem. Biol., in press.
14. He, J., and C. Hertweck. 2005. Functional analysis of the aureothin iterative type I polyketide synthase. ChemBioChem 6:908-912.
15. Hodgkin, J., and D. Kaiser. 1977. Cell-to-cell stimulation of movement in non-motile mutant of Myxococcus. Proc. Natl. Acad. Sci. USA 74:2932-2942.
16. Irschik, H., R. Jansen, K. Gerth, G. Höfle, and H. Reichenbach. 1995. Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria. J. Antibiot. 48:962-966.
17. Jansen, R., H. Irschik, H. Reichenbach, V. Wray, and G. Höfle. 1994. Disorazoles, highly cytotoxic metabolites from the Sorangicin-producing bacterium Sorangium cellulosum, strain So ce12. Liebigs Ann. Chem. 8:759-773.
18. Julien, B., and S. Shah. 2002. Heterologous expression of epothilone biosynthetic genes in Myxococcus xanthus. Antimicrob. Agents Chemother. 46:2772-2778.
19. Kunze, B., H. Reichenbach, R. Müller, and G. Höfle. 2005. Aurafuron A and B, new bioactive polyketides from Stigmatella aurantiaca and Archangium gephyra (myxobacteria). J. Antibiot. 58:244-251.
20. Lambalot, R. H., A. M. Gehring, R. S. Flugel, P. Zuber, M. LaCelle, M. A. Marahiel, R. Reid, C. Khosla, and C. T. Walsh. 1996. A new enzyme superfamily: the phosphopantetheinyl transferases. Chem. Biol. 3:923-936.
21. Lau, J., S. Frykman, R. Regentin, S. Ou, H. Tsuruta, and P. Licari. 2002. Optimizing the heterologous production of epothilone D in Myxococcus xanthus. Biotechnol. Bioeng. 78:280-288.
22. Mahmud, T., H. B. Bode, B. Silakowski, R. M. Kroppenstedt, M. Xu, S. Nordhoff, G. Höfle, and R. Müller. 2002. A novel biosynthetic pathway providing precursors for fatty acid biosynthesis and secondary metabolite formation in myxobacteria. J. Biol. Chem. 277:23768-32774.
23. Mahmud, T., S. C. Wenzel, E. Wan, K. W. Wen, H. B. Bode, N. Gaitatzis, and R. Müller. 2005. A novel biosynthetic pathway to isovaleryl-CoA in myxobacteria: the involvement of the mevalonate pathway. ChemBioChem 6:322-330.
24. m promoter of the TOL plasmid of Pseudomonas putida. Mol. Microbiol. 18:851-857.
25. Mermod, N., P. R. Lehrbach, W. Reineke, and K. N. Timmis. 1984. Transcription of the TOL plasmid toluate catabolic pathway operon of Pseudomonas putida is determined by a pair of co-ordinately and positively regulated overlapping promoters. EMBO J. 3:2461-2466.
26. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
27. Morrison, C. E., and D. R. Zusman. 1979. Myxococcus xanthus mutants with temperature-sensitive, stage-specific defects: evidence for independent pathways in development. J. Bacteriol. 140:1036-1042.
28. Müller, I., S. Weinig, H. Steinmetz, B. Kunze, S. Veluthoor, T. Mahmud, and R. Müller. A unique mechanism for methyl ester formation via an amide intermediate found in myxobacteria. ChemBioChem 7:1197-1205.
29. Niggemann, J., M. Herrmann, K. Gerth, H. Irschik, H. Reichenbach, and G. Höfle. 2004. Tuscolid and tuscoron A and B: isolation, structural elucidation and studies on the biosynthesis of novel Furan-3(2H)-one-containing metabolites from the myxobacterium Sorangium cellulosum. Eur. J. Org. Chem. 2004:487-492.
30. Peiru, S., H. G. Menzella, E. Rodriguez, J. Carney, and H. Gramajo. 2005. Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl. Environ. Microbiol. 71:2539-2547.
31. Reichenbach, H. 2001. Myxobacteria, producers of novel bioactive substances. J. Ind. Microbiol. Biotechnol. 27:149-156.
32. Reichenbach, H., and G. Höfle. 1999. Myxobacteria as producers of secondary metabolites, p. 149-179. In S. Grabley and R. Thiericke (ed.), Drug discovery from nature. Springer, Berlin, Germany.
33. Sasse, F., H. Steinmetz, J. Heil, G. Höfle, and H. Reichenbach. 2000. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli: production, isolation, physico-chemical and biological properties. J. Antibiot. 53:879-885.
34. Schulz, S., J. Fuhlendorff, and H. Reichenbach. 2004. Identification and synthesis of volatiles released by the myxobacterium Chondromyces crocatus. Tetrahedron 60:3863-3872.
35. Silakowski, B., B. Kunze, and R. Müller. 2001. Multiple hybrid polyketide synthase/non-ribosomal peptide synthetase gene clusters in the myxobacterium Stigmatella aurantiaca. Gene 275:233-240.
36. Silakowski, B., H. U. Schairer, H. Ehret, B. Kunze, S. Weinig, G. Nordsiek, P. Brandt, H. Blöcker, G. Höfle, S. Beyer, and R. Müller. 1999. New lessons for combinatorial biosynthesis from myxobacteria: the myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1. J. Biol. Chem. 274:37391-37399.
37. Simunovic, V., J. Zapp, S. Rachid, D. Krug, P. Meiser, and R. Müller. Myxovirescin biosynthesis is directed by an intriguing megasynthetase consisting of hybrid polyketide synthases/nonribosomal peptide synthetase, 3-hydroxy-3-methylglutaryl CoA synthases, and trans-acting acyltransferases. ChemBioChem 7:1206-1220.
38. Steinmetz, H., E. Forche, H. Reichenbach, and G. Höfle. 2000. Biosynthesis of myxothiazol Z, the ester-analog of myxothiazol A in Myxococcus fulvus. Tetrahedron 56:1681-1684.
39. Tang, L., S. Shah, L. Chung, J. Carney, L. Katz, C. Khosla, and B. Julien. 2000. Cloning and heterologous expression of the epothilone gene cluster. Science 287:640-642.
40. Trowitzsch, W., G. Reifenstahl, V. Wray, and G. Höfle. 1980. Myxothiazol, an antibiotic from Myxococcus fulfus (Myxobacterales) II. Structure elucidation. J. Antibiot. 33:1480-1490.
41. Trowitzsch-Kienast, W., V. Wray, K. Gerth, H. Reichenbach, and G. Höfle. 1986. Antibiotika aus Gleitenden Bakterien. XXVIII. Biosynthese des Myxothiazols in Myxococcus fulvus Mx f16. Liebigs Ann. Chem. 10:93-98.
42. Vetcher, L., Z. Q. Tian, R. McDaniel, A. Rascher, W. P. Revill, C. R. Hutchinson, and Z. Hu. 2005. Rapid engineering of the geldanamycin biosynthesis pathway by Red/ET recombination and gene complementation. Appl. Environ. Microbiol. 71:1829-1835.
43. Weinig, S., T. Mahmud, and R. Müller. 2003. Markerless mutations in the myxothiazol biosynthetic gene cluster: a delicate megasynthetase with a superfluous nonribosomal peptide synthetase domain. Chem. Biol. 10:953-960.
44. Wenzel, S., and R. Müller. 2005. Recent developments toward the heterologous expression of complex bacterial natural product biosynthetic pathways. Curr. Opin. Biotechnol. 16:594-606.
45. Wenzel, S. C., F. Gross, Y. Zhang, J. Fu, F. A. Stewart, and R. Müller. 2005. Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via red/ET recombineering. Chem. Biol. 12:349-356.
46. Wenzel, S. C., B. Kunze, G. Höfle, B. Silakowski, M. Scharfe, H. Blöcker, and R. Müller. 2005. Structure and biosynthesis of myxochromides S1-3 in Stigmatella aurantiaca: evidence for an iterative bacterial type I polyketide synthase and for module skipping in nonribosomal peptide biosynthesis. ChemBioChem 6:375-385.
47. Zhang, Y., F. Buchholz, J. Muyrers, and F. Stewart. 1998. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 20:123-128.
48. Zhang, Y., J. Muyrers, G. Testa, and A. Stewart. 2000. DNA cloning by homologous recombination in Escherichia coli. Nat. Biotechnol. 18:1314-1317.
49. Zirkle, R., J. M. Ligon, and I. Molnar. 2004. Heterologous production of the antifungal polyketide antibiotic soraphen A of Sorangium cellulosum So ce26 in Streptomyces lividans. Microbiology 150:2761-2774.